← 홈

천식 · IL-4R

3개 · ADC 1048 · Antibody 5323 · CGT 2737 · 다음 갱신 D-13 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3개
AntibodyAHOTFDACuratedFDABiologicSanofiApproved

dupilumab (Dupixent)

Atopic dermatitis, asthma, CRSwNP, EoE · IL-4Rα

#IL-4R#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 0.45%임상시험 228상태 APPROVED
AntibodystaleSanofiPhase 3

Dupilumab/Dupixent (Dupilumab/Dupixent)

Asthma · Asthma

#Asthma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING